Search

everythinglearnresearchcommunity

for

Search:↓

Developing microRNA-based treatments is hard but has potential.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

Fascial Manipulation treatment helped a woman with vulvodynia and other health issues.

New app improves storm surge predictions; advances in baldness treatment show potential but require time.

PRP is more effective than minoxidil and placebo for treating hair loss.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Metformin is less effective in men with early-onset hair loss.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Sonicated platelet-rich plasma boosts hair growth by activating stem cells.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

The best mix for a hair loss treatment cream is 10% Sophora japonica tincture and 5% Serenoa repens extract.

Stem cell treatments show promise for hair loss but need more research.

Men with lower 2nd to 4th finger ratios tend to have larger sinus volumes.

Combining finasteride with minoxidil is more effective for male hair loss than using minoxidil alone.

People with male pattern baldness are more likely to have metabolic syndrome.

The document explains how male reproductive hormones work and affect the body.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

The document explains hair growth, hair loss types, and other hair-related terms.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

A gene called HDAC9 might be a new factor in male-pattern baldness.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Finasteride discontinuation increases sperm count in men.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PCOS has a strong genetic basis, but more research is needed to fully understand it.